Vidyya Medical News Service
*
Volume 6 Issue 119 Published - 14:00 UTC 08:00 EST 28-Apr-2004 Next Update - 14:00 UTC 08:00 EST 29-Apr-2004
little clear gif used for spacer
.
*

Future blood tests may use tiny bar-codes to speed disease diagnosis
Analyzing a blood sample for the presence of disease markers, either in a doctor's office or on the battlefield, could soon become as quick and easy as scanning the bar-code of a grocery item. Using nanotechnology, researchers at Northwestern University have developed a way to label tiny disease markers in blood with unique DNA tags, which they call bio-bar-codes. The tags can then be scanned by an instrument to identify diseases ranging from cancer to Alzheimer's, or identify exposure to bioterror agents such as anthrax and smallpox, they say.  more

*
Illegal drug use causes painful complications for oncology patients
The Substance Abuse and Mental Health Services Administration reports that eight percent of people ages 12 and older have used illicit drugs within the past month. Because drug use is surprisingly common within our society, those who need prescription medicine to treat pain often have a hard time obtaining it. more

*
FDA requires pancreatic extract manufacturers to submit marketing applications
The Food and Drug Administration (FDA) formally notified manufacturers of pancreatic insufficiency products that these drugs must get approval by FDA within the next four years in order to remain on the market. FDA decided to require approval of new drug applications (NDAs) for all pancreatic extract drug products after reviewing data that showed substantial variations among currently marketed products.  more

 


*
Winning the battle of the bulge: We're a scrimmage closer to victory
Saint Louis University researchers believe they've won a major skirmish in the battle of the bulge, and their findings are published in the May issue of Diabetes.  more

*
Questions and answers on exocrine pancreatic insufficiency drug products
PEPs aid in the digestion of meals in patients who have diseases affecting their pancreatic function. PEPs contain the ingredients pancreatin and pancrelipase, both of which contain the enzymes lipase, protease, and amylase. These enzymes break down fats (lipase), proteins (protease) and complex carbohydrates (amylase) to allow absorption of these nutrients into the body. more

*
HIV patients get long-term boost with short, intermittent drug regimen
National Institutes of Health (NIH) scientists report that brief, widely-spaced courses of the experimental immune-boosting drug interleukin-2 (IL-2) allow people with HIV to maintain near normal levels of a key immune system cell for long periods. The researchers, from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and the Warren G. Magnuson Clinical Center, describe their findings in the 1 May 2004 issue of the journal Blood.  more

*
Survey shows new Mayo Clinic treatment for intractable low blood pressure
Patients are generally pleased with a new Mayo Clinic drug treatment for a common form of impaired nerve transmission that causes dizziness and fainting when patients change position from lying down to standing up, and most want to continue using it.  more

 
little clear gif used for a space